Impact of diabetes on five-year outcomes after vein graft interventions performed prior to the drug-eluting stent era

Journal of Invasive Cardiology

Volumn 18, Issue 3, 2006, Pages 100-105

  Ashfaq, Salman ^a   Ghazzal, Ziyad ^a   Douglas, John S ^a   Morris, Douglas C ^a   Veledar, Emir ^a   Weintraub, William S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ELUTING STENT; ELECTRONIC MEDICAL RECORD; EVALUATION; FEMALE; HAZARD ASSESSMENT; HISTORY OF MEDICINE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROTECTIVE EQUIPMENT; SAPHENOUS VEIN GRAFT; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOLOGY; CORONARY DISEASE; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RETREATMENT; SAPHENOUS VEIN; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33645850700     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-626.
2. Bourassa MG, Enjalbert M, Campeau L, et al. Progression of atherosclerosis in coronary arteries and bypass grafts: Ten years later. Am J Cardiol 1984;53:102C-107C.
3. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition and prevention. Circulation 1998;97:916-931.
4. Kereiakes D. Platelet Glycoprotein IIb/IIIa Inhibition and atheroembolism during bypass graft angioplasty: A cup half full (editorial). Circulation 2002;106:2994-2996.
5. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol 2001;38:150-154.
6. Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines). J Am Coll Cardiol 2001;37:2215-2238.
7. de Feyter PJ, van Suylen RJ, de Jaegere PP, et al. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol 1993;21:1539-1549.
8. Ellis SG, Narins CR. Problem of angioplasty in diabetics. Circulation 1997;96:1707-1710.
9. Shaw RE, Anderson VE, Weintraub WS, et al. Development of a risk adjustment mortality model from the ACC-NCDR experience: 1998-2000. J Am Coll Cardiol 2002;39:1104-1112.
10. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-2038.
11. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1980;3:650-654.
12. Abizaid A, Kornowski R, Mintz GS, et al. The influence of diabetes mellitus on acute and late the clinical outcomes following coronary stent placement. J Am Coll Cardiol 1998;32:584-589.
13. Stein B, Weintraub WS, Gebhart SS, et al. Influence of diabetes mellitus on early and late clinical outcomes after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-989.
14. Ghazzal Z, Ashfaq S, Douglas JS, et al. Prognostic implication of creatine kinase release following elective percutaneous coronary intervention in the pre-IIb-IIIa antagonist era. Am Heart J 2003;145:1006-1012.
15. Mathew V, Clavell AL, Lennon RJ, et al. Percutaneous coronary interventions in patients with prior coronary artery bypass surgery: Changes in patient characteristics and outcome during two decades. Am J Med 2000;108:127-235.
16. Baim DS, Wahr D, George B, et al. Randomized trial of distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-1290.
17. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003;108:548-553.
18. Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004;109:1942-1947.
19. Morice MC, Serruys PW, Sousa E, et al. Randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. N Engl J Med 2002;346:1773-1780.
20. Ge L, Iakovou I, Sangiorgi GM, et al. Treatment of saphenous vein graft lesions with drug-eluting stents: Immediate and midterm outcome. J Am Coll Cardiol 2005;43:989-994.
21. Douglas JS, King SB III. Percutaneous coronary interventions. In: Fuster V, Alexander RW, O'Rourke RA, et al. (Eds.) Hurst's The Heart, 10th Edition. 2001, pp. 1437-1470.
22. Cox DR. Regression models and life tables. J R Stat Soc Bzvol 1972;34:187-202.
23. Harrell F. Design: S Functions for biostatistical/epidemiological modeling, testing, estimation, validation, graphics, prediction, and typesetting. Programs available from statlib@lib.stat.cmu.edu.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
25. Ahmed JM, Hong MK, Mehran R, et al. Influence of diabetes mellitus on early and late clinical outcomes in saphenous vein graft stenting. J Am Coll Cardiol 2000;36:1186-1193.
26. Heidland UE, Heintzen MP, Michel CJ, et al. Risk factors for the development of restenosis following stent implantation of venous bypass grafts. Heart 2001;85:312-317.
27. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty inpatients with multivessel disease. N Engl J Med 1996;335:217-225.
28. Alderman EL, Corley SD, Fisher LD, et al. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol 1993;22:1141-1154.
29. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153.
30. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE study. Lancet 2000;355:253-259.
31. Lewis EJ, Hunsicker LG, Bain RP, et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
32. Wong SC, Baim DS, Schatz RA, et al. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: The multicenter U.S. Palmaz-Schatz stent experience. J Am Coll Cardiol 1995;26:704-712.
33. Savage MP, Douglas JS, Fischman DL, et al. for the Saphenous Vein de novo (SAVED) investigators. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med 1997;337:740-747.
34. Brener SJ, Ellis GS Apperson-Hansonn C, et al. Comparison of stenting and balloon angioplasty for marrowings in aorto-coronary saphenous vein conduits in place for more than 5 years. Am J Cardiol 1997;79:13-18.
35. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000;23:1108-1112.
36. Roffi M, Mukherjee D, Chew DP, et al. Lack of benefit from intravenous platelet glycoprotein IIb/IIIa receptor inhibition as adjunctive treatment for percutaneous interventions of aortocoronary bypass grafts: A pooled analysis of five randomized clinical trials. Circulation 2002;106:3063-3067.